Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enavogliflozin in Amyloid Cardiomyopathy
NCT07240844Phase 4Recruiting
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Jan 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enavogliflozin in amyloid cardiomyopathy, sponsored by Seoul St. Mary's Hospital. Started Jan 2026; status: recruiting.
02
Drugs
enavogliflozin
03
Conditions
amyloid cardiomyopathy
Beyond the preview
Go deeper on NCT07240844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240844.